Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 21, 2026 06:54 ET | Source: Li-FT Power Ltd.

LIFT Completes Combination With Winsome Resources

VANCOUVER, British Columbia, May 21, 2026 (GLOBE NEWSWIRE) -- Li-FT Power Ltd. (“LIFT” or the “Company”) (TSXV: LIFT) (OTCQX: LIFFF) (Frankfurt: WS0) is pleased to announce the successful completion...
May 19, 2026 20:00 ET | Source: Deutsche Aircraft Gmbh

Deutsche Aircraft Signals Long-Term Commitment to Australia at RAAA Convention, Positioning D328eco® for Regional Connectivity Needs

Cairns, May 19, 2026 (GLOBE NEWSWIRE) -- Iconic German regional aviation company Deutsche Aircraft is set to have a high-profile entry at the 2026 Regional Aviation Association of Australia (RAAA)...
April 20, 2026 08:15 ET | Source: PharmAla Biotech

PharmAla Biotech Positioned to Supply U.S. Expanded Access Pathway for MDMA Established by Presidential Executive Order

PharmAla is positioned to supply the US market with MDMA, and is advancing its next-generation patented safer MDMA product for human dosing this year.
April 15, 2026 07:40 ET | Source: Tilray Brands, Inc.

Tilray Brands Accelerates Next Phase of Global Growth and Market Leadership

NEW YORK and LEAMINGTON, Ontario, April 15, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”, “our”, “we” or the “Company”) (NASDAQ: TLRY; TSX: TLRY), a global lifestyle and consumer packaged...
April 13, 2026 07:00 ET | Source: Copenhagen Infrastructure Partners

Copenhagen Infrastructure Partners divests ownership of Summerfield Battery to Palisade Investment Partners

CIP is selling its Summerfield BESS project to Palisade. It is a 240 MW / 960 MWh 4-hour late-stage construction project near Adelaide in South Australia.
April 08, 2026 09:15 ET | Source: Psyence Biomedical Ltd.

Psyence BioMed Expands Australian Clinical Site Network to Five Sites, Advancing NPX-5–Supported Clinical Activities

NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine...
March 31, 2026 15:41 ET | Source: DIT AgTech

DIT AgTech Launches Investment Campaign to Scale Precision Livestock Nutrition Solutions

Toowoomba, Australia, March 31, 2026 (GLOBE NEWSWIRE) -- DIT AgTech, a leader in precision livestock nutrition and delivery technology, has launched its Regulation Crowdfunding (Reg CF) investment...
March 24, 2026 08:00 ET | Source: Calidi Biotherapeutics, Inc

Calidi Biotherapeutics Announces Partnership with Avance Clinical to Facilitate Australian Regulatory Approval and Accelerate Initiation of CLD-401 Clinical Trials

SAN DIEGO, March 24, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic...
March 23, 2026 09:00 ET | Source: PharmAla Biotech

Cortexa Advances Commercialisation of MDMA Supply in Australia

PharmAla provides an update on Cortexa, its Australian joint venture with Vitura Health.
March 19, 2026 07:00 ET | Source: Tilray Brands, Inc.

Tilray Medical Announces Major Expansion of Medical Cannabis Portfolio in Australia

NEW YORK and SYDNEY, March 19, 2026 (GLOBE NEWSWIRE) -- Tilray Medical, a recognized global leader in medical cannabis and a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY),...